seres therapeutics stock price target
Stock quote stock chart quotes analysis advice financials and news for share SERES THERAPEUTICS INC. 1 day agoCertain Common Stock of Seres Therapeutics Inc.
Analysts Set Seres Therapeutics Inc Nasdaq Mcrb Price Target At 36 90 Opera News
That is 10467 above the last closing price of 642.
. Are subject to a Lock-Up Agreement End. Common Stock MCRB Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Seres Therapeutics Stock Forecast Invest in MCRB NASDAQMCRB.
Stock Price Forecast The 7 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 1200 with a high estimate of 2500 and a low estimate of 400. The analyst consensus target price for shares in Seres Therapeutics is 1314. The current price of Seres Therapeutics is the price at.
Analyst ratings historical stock prices earnings estimates actuals. Seres Therapeutics stock price target cut to 13 from 44 at BofA Merrill Lynch Aug. 658 Average target price.
5 rows According to 1 Wall Street analyst that have issued a 1 year MCRB price target the average MCRB. Analysts covering Seres Therapeutics currently have a. Find the latest Seres Therapeutics Inc.
2500 Spread Highest target. MCRB stock quote history news and other vital information to help you with your stock trading and investing. The current price Seres Therapeutics MCRB is trading at is 591 which is out of the analysts predicted range.
High Price Target. 1 2016 at 1111 am. Seres Therapeutics Target Price Projection Seres Therapeutics current and average target prices are 693 and 2283 respectively.
Browse analyst ratings and price targets on all stocks. Last Close Price. MCRB updated stock price target summary.
Price Target Based on short-term price targets offered by five analysts the average price target for Seres Therapeutics comes to 1420. Chardan Capital Lowers Seres Therapeutics Price Target to 12. Seres Therapeutics stock forecast analyst price target predictions based on 4 analysts offering 12-months price targets for MCRB in the last 3 months.
Stock Price Target MCRB. The forecasts range from a low of 900. Find the latest Seres Therapeutics Inc MCRB stock price forecast 12-month price target predictions and analyst recommendations.
ET by Tomi Kilgore Seres Therapeutics downgraded to neutral from buy at BofA. The 10 analysts offering price forecasts for Seres Therapeutics have a median target of 2290 with a high estimate of 4600 and a low estimate of 700. 1314 Spread Average Target.
Deutsche Boerse AG.
Design Therapeutics Nasdaqgs Dsgn Stock Price Quote Analysis Simply Wall St
Seres Therapeutics Mcrb Stock Price Quote News Analysis Tipranks
Mcrb Stock Price Forecast Should You Buy Mcrb
Will The Rally Continue In Seres Therapeutics Mcrb Stock After A Stellar 77 Surge In A Month Trefis
Seres Therapeutics Mcrb Stock Price News Info The Motley Fool
Seres Therapeutics The Case For Seres Investment Strengthen Nasdaq Mcrb Seeking Alpha
Cancer Fighting Biotechs Jump 1 000 In Shadow Of Covid Stocks Bnn Bloomberg
Seres Therapeutics Mcrb Nestle Health Science Announce Joint Ser 109 Commercialization License Agreement
Seres Therapeutics Reports Weak Earnings But Significant Upside Lies Ahead
Seres Therapeutics Stock Nasdaq Mcrb Quotes And News Summary Benzinga
Mcrb Stock Price And Chart Nasdaq Mcrb Tradingview
Seres Therapeutics Stock Forecast Down To 0 000000007 Usd Mcrb Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis
Seres Therapeutics Mcrb Stock Why The Price Increased Today
Seres Therapeutics Stock Here We Go Again Nasdaq Mcrb Seeking Alpha
Seres Therapeutics Rallies 14 As Insider Flagship Pioneering Increases Stake Nasdaq
Mcrb Seres Therapeutics Inc Stock Overview U S Nasdaq Barron S
Seres Therapeutics Biotech Reviews
Anaptysbio Nasdaqgs Anab Stock Price Quote Analysis Simply Wall St
Is Seres Therapeutics Still A Buy After Disappointing Ser 287 Topline Results